CNR1 and obesity disorder: Therefore, CB1R has been regarded as an attractive therapeutic target for obesity for the past two decades (Di Marzo et al., 2011; Gatta-Cherifi and Cota, 2015; Kaur et al., 2016; Lu et al., 2016).